PATH-17. HYPERPROGRESSIVE DISEASE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMAS TREATED WITH IMMUNE CHECKPOINT INHIBITORS OR CYTOTOXIC THERAPIES

Authors: Laura Donovan, Samuel Gedailovich, Adela Joanta-Gomez, Andrew Lassman, Fabio Iwamoto

Published: 2019-11-11

DOI: 10.1093/neuonc/noz175.613

Source: Full article